Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric C Strain

Showing results (131-140 of 160) with videos related to

Pageof 16
Sort By:
The Journal of Pain|June 1, 2022
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of PsychedelicsRobert H Dworkin, Brian T Anderson, Nick Andrews, et al.
Preventive Medicine|March 11, 2014
The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trialAugust F Holtyn, Mikhail N Koffarnus, Anthony DeFulio, et al.
Science Translational Medicine|June 22, 2022
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taperAndrew S Huhn, Patrick H Finan, Charlene E Gamaldo, et al.
Drug and Alcohol Dependence|July 3, 2021
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphoneGabrielle Agin-Liebes, Andrew S Huhn, Eric C Strain, et al.
Addiction Biology|January 15, 2024
Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessmentKelly E Dunn, Andrew S Huhn, Patrick H Finan, et al.
Drug and Alcohol Dependence|May 23, 2022
Gender parity and homophily in the Drug and Alcohol Dependence editorial processMelissa R Schick, Rachel L Tomko, Anna M Maralit, et al.
Experimental and Clinical Psychopharmacology|February 20, 2014
Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose levelOlga Rass, Bethea A Kleykamp, Ryan G Vandrey, et al.
Journal of Opioid Management|December 25, 2012
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocolAndrew Rosenblum, Ricardo A Cruciani, Eric C Strain, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2025
Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotypeJennifer D Ellis, Eleanor Blair Towers, Kelly E Dunn, et al.
Drug and Alcohol Dependence|April 4, 2006
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel reportCharles Grudzinskas, Robert L Balster, Charles W Gorodetzky, et al.
Pageof 16

Showing results (131-140 of 160) with videos related to

Sort By:
Pageof 16
The Journal of Pain|June 1, 2022
If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of PsychedelicsRobert H Dworkin, Brian T Anderson, Nick Andrews, et al.
Preventive Medicine|March 11, 2014
The therapeutic workplace to promote treatment engagement and drug abstinence in out-of-treatment injection drug users: a randomized controlled trialAugust F Holtyn, Mikhail N Koffarnus, Anthony DeFulio, et al.
Science Translational Medicine|June 22, 2022
Suvorexant ameliorated sleep disturbance, opioid withdrawal, and craving during a buprenorphine taperAndrew S Huhn, Patrick H Finan, Charlene E Gamaldo, et al.
Drug and Alcohol Dependence|July 3, 2021
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphoneGabrielle Agin-Liebes, Andrew S Huhn, Eric C Strain, et al.
Addiction Biology|January 15, 2024
Polymorphisms in the A118G SNP of the OPRM1 gene produce different experiences of opioids: A human laboratory phenotype-genotype assessmentKelly E Dunn, Andrew S Huhn, Patrick H Finan, et al.
Drug and Alcohol Dependence|May 23, 2022
Gender parity and homophily in the Drug and Alcohol Dependence editorial processMelissa R Schick, Rachel L Tomko, Anna M Maralit, et al.
Experimental and Clinical Psychopharmacology|February 20, 2014
Cognitive performance in methadone maintenance patients: effects of time relative to dosing and maintenance dose levelOlga Rass, Bethea A Kleykamp, Ryan G Vandrey, et al.
Journal of Opioid Management|December 25, 2012
Sublingual buprenorphine/naloxone for chronic pain in at-risk patients: development and pilot test of a clinical protocolAndrew Rosenblum, Ricardo A Cruciani, Eric C Strain, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|November 19, 2025
Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotypeJennifer D Ellis, Eleanor Blair Towers, Kelly E Dunn, et al.
Drug and Alcohol Dependence|April 4, 2006
Impact of formulation on the abuse liability, safety and regulation of medications: the expert panel reportCharles Grudzinskas, Robert L Balster, Charles W Gorodetzky, et al.
Pageof 16